An exopolysaccharide-deficient mutant of Lactobacillus rhamnosus GG efficiently displays a protective llama antibody fragment against rotavirus on its surface

Applied and Environmental Microbiology

Volumn 81, Issue 17, 2015, Pages 5784-5793

  Álvarez, Beatriz ^a,b,e   Krogh Andersen, Kasper ^a   Tellgren Roth, Christian ^c   Martínez, Noelia ^d   Günaydin, Gökçe ^a   Lin, Yin ^a   Martín, M Cruz ^d   Álvarez, Miguel A ^d   Hammarström, Lennart ^a   Marcotte, Harold ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSIDAD AUTÓNOMA DE CHILE   (Chile)

^c UPPSALA UNIVERSITY   (Sweden)

^d DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^e CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLI; DEVELOPING COUNTRIES; METABOLITES; SURFACE DEFECTS; VACCINES;

ALTERNATIVE THERAPY; BACTERIAL SURFACES; DEVELOPED COUNTRIES; EXOPOLYSACCHARIDES; GASTROINTESTINAL TRACT; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS STRAINS; PROBIOTIC BACTERIA;

ANTIBODIES;

ANTIBODY; BACTERIUM; DEVELOPING WORLD; ECOLOGICAL MODELING; FRAGMENTATION; GENOMICS; MUTATION; POLYSACCHARIDE; VACCINATION; VIRUS;

BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; LAMA (MAMMAL); ROTAVIRUS;

BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; IMMUNOGLOBULIN FRAGMENT; PROBIOTIC AGENT;

ANIMAL; BAGG ALBINO MOUSE; DEFICIENCY; DISEASE MODEL; FEMALE; GENETICS; HUMAN; LACTOBACILLUS RHAMNOSUS; MALE; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; MOUSE; PHYSIOLOGY; ROTAVIRUS; ROTAVIRUS INFECTIONS; VIROLOGY;

ANIMALS; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOGLOBULIN FRAGMENTS; LACTOBACILLUS RHAMNOSUS; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES, BACTERIAL; PROBIOTICS; ROTAVIRUS; ROTAVIRUS INFECTIONS;

EID: 84938819371     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00945-15     Document Type: Article

References (47)

1. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2012. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and metaanalysis. Lancet Infect Dis 12:136-141. http://dx.doi.org/10.1016/S1473-3099(11)70253-5.
2. Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson KF, Ansah NA, Levine MM, Lewis K, Coia ML, Attah-Poku M, Ojwando J, Rivers SB, Victor JC, Nyambane G, Hodgson A, Schodel F, Ciarlet M, Neuzil KM. 2010. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 376:606-614. http://dx.doi.org/10.1016/S0140-6736(10)60889-6.
3. Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, Han HH, Neuzil KM. 2010. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 362:289-298. http://dx.doi.org/10.1056/NEJMoa0904797.
4. Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TP, Luby SP, Le HT, Coia ML, Lewis K, Rivers SB, Sack DA, Schodel F, Steele AD, Neuzil KM, Ciarlet M. 2010. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebocontrolled trial. Lancet 376:615-623. http://dx.doi.org/10.1016/S0140-6736(10)60755-6.
5. Glass RI, Parashar UD. 2006. The promise of new rotavirus vaccines. N Engl J Med 354:75-77. http://dx.doi.org/10.1056/NEJMe058285.
6. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, López P, Macías-Parra M, Ortega-Barría E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavía-Ruz N, Salmerón J, Rüttimann R, Tinoco JC, Rubio P, Nuñez E, Guerrero ML, Yarzábal JP, Damaso S, Tornieporth N, Sáez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M. 2006. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354:11-22. http://dx.doi.org/10.1056/NEJMoa052434.
7. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CDC, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM. 2006. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354:23-33. http://dx.doi.org/10.1056/NEJMoa052664.
8. Garaicoechea L, Olichon A, Marcoppido G, Wigdorovitz A, Mozgovoj M, Saif L, Surrey T, Parreno V. 2008. Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice. J Virol 82:9753-9764. http://dx.doi.org/10.1128/JVI.00436-08.
9. van der Vaart JM, Pant N, Wolvers D, Bezemer S, Hermans PW, Bellamy K, Sarker SA, van der Logt CP, Svensson L, Verrips CT, Hammarstrom L, van Klinken BJ. 2006. Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llamaderived antibody fragments. Vaccine 24:4130-4137. http://dx.doi.org/10.1016/j.vaccine.2006.02.045.
10. Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa EB, Bendahman N, Hamers R. 1993. Naturally occurring antibodies devoid of light chains. Nature 363:446-448. http://dx.doi.org/10.1038/363446a0.
11. Frenken LG, van der Linden RH, Hermans PW, Bos JW, Ruuls RC, de Geus B, Verrips CT. 2000. Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J Biotechnol 78:11-21. http://dx.doi.org/10.1016/S0168-1656(99)00228-X.
12. Dolk E, van Vliet C, Perez JM, Vriend G, Darbon H, Ferrat G, Cambillau C, Frenken LG, Verrips T. 2005. Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen. Proteins 59:555-564. http://dx.doi.org/10.1002/prot.20378.
13. van der Linden RH, Frenken LG, de Geus B, Harmsen MM, Ruuls RC, Stok W, de Ron L, Wilson S, Davis P, Verrips CT. 1999. Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies. Biochim Biophys Acta 1431:37-46. http://dx.doi.org/10.1016/S0167-4838(99)00030-8.
14. Pant N, Hultberg A, Zhao Y, Svensson L, Pan-Hammarstrom Q, Johansen K, Pouwels PH, Ruggeri FM, Hermans P, Frenken L, Boren T, Marcotte H, Hammarstrom L. 2006. Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea. J Infect Dis 194:1580-1588. http://dx.doi.org/10.1086/508747.
15. Aladin F, Einerhand AW, Bouma J, Bezemer S, Hermans P, Wolvers D, Bellamy K, Frenken LG, Gray J, Iturriza-Gomara M. 2012. In vitro neutralisation of rotavirus infection by two broadly specific recombinant monovalent llama-derived antibody fragments. PLoS One 7:e32949. http://dx.doi.org/10.1371/journal.pone.0032949.
16. Sarker SA, Jakel M, Sultana S, Alam NH, Bardhan PK, Chisti MJ, Salam MA, Theis W, Hammarstrom L, Frenken LG. 2013. Anti-rotavirus protein reduces stool output in infants with diarrhea: a randomized placebo-controlled trial. Gastroenterology 145:740-748.e748. http://dx.doi.org/10.1053/j.gastro.2013.06.053.
17. Martin MC, Pant N, Ladero V, Gunaydin G, Andersen KK, Alvarez B, Martinez N, Alvarez MA, Hammarstrom L, Marcotte H. 2011. Integrative expression system for delivery of antibody fragments by lactobacilli. Appl Environ Microbiol 77:2174-2179. http://dx.doi.org/10.1128/AEM.02690-10.
18. Siezen RJ. 1999. Multi-domain, cell-envelope proteinases of lactic acid bacteria. Antonie Van Leeuwenhoek 76:139-155. http://dx.doi.org/10.1023/A:1002036906922.
19. Guandalini S. 2011. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol 45(Suppl):S149-S153. http://dx.doi.org/10.1097/MCG.0b013e3182257e98.
20. Kankainen M, Paulin L, Tynkkynen S, von Ossowski I, Reunanen J, Partanen P, Satokari R, Vesterlund S, Hendrickx AP, Lebeer S, De Keersmaecker SC, Vanderleyden J, Hamalainen T, Laukkanen S, Salovuori N, Ritari J, Alatalo E, Korpela R, Mattila-Sandholm T, Lassig A, Hatakka K, Kinnunen KT, Karjalainen H, Saxelin M, Laakso K, Surakka A, Palva A, Salusjarvi T, Auvinen P, de Vos WM. 2009. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proc Natl Acad Sci U S A 106:17193-17198. http://dx.doi.org/10.1073/pnas.0908876106.
21. Brandt K, Alatossava T. 2003. Specific identification of certain probiotic Lactobacillus rhamnosus strains with PCR primers based on phage-related sequences. Int J Food Microbiol 84:189-196. http://dx.doi.org/10.1016/S0168-1605(02)00419-1.
22. Martin MC, Alonso JC, Suarez JE, Alvarez MA. 2000. Generation of food-grade recombinant lactic acid bacterium strains by site-specific recombination. Appl Environ Microbiol 66:2599-2604. http://dx.doi.org/10.1128/AEM.66.6.2599-2604.2000.
23. De Keersmaecker SC, Braeken K, Verhoeven TL, Perea Velez M, Lebeer S, Vanderleyden J, Hols P. 2006. Flow cytometric testing of green fluorescent protein-tagged Lactobacillus rhamnosus GG for response to defensins. Appl Environ Microbiol 72:4923-4930. http://dx.doi.org/10.1128/AEM.02605-05.
24. Perez-Arellano I, Zuniga M, Perez-Martinez G. 2001. Construction of compatible wide-host-range shuttle vectors for lactic acid bacteria and Escherichia coli. Plasmid 46:106-116. http://dx.doi.org/10.1006/plas.2001.1531.
25. Kruger C, Hu Y, Pan Q, Marcotte H, Hultberg A, Delwar D, van Dalen PJ, Pouwels PH, Leer RJ, Kelly CG, van Dollenweerd C, Ma JK, Hammarstrom L. 2002. In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat Biotechnol 20:702-706. http://dx.doi.org/10.1038/nbt0702-702.
26. Marcotte H, Koll-Klais P, Hultberg A, Zhao Y, Gmur R, Mandar R, Mikelsaar M, Hammarstrom L. 2006. Expression of single-chain antibody against RgpA protease of Porphyromonas gingivalis in Lactobacillus. J Appl Microbiol 100:256-263. http://dx.doi.org/10.1111/j.1365-2672.2005.02786.x.
27. Koskenniemi K, Laakso K, Koponen J, Kankainen M, Greco D, Auvinen P, Savijoki K, Nyman TA, Surakka A, Salusjarvi T, de Vos WM, Tynkkynen S, Kalkkinen N, Varmanen P. 2011. Proteomics and transcriptomics characterization of bile stress response in probiotic Lactobacillus rhamnosus GG. Mol Cell Proteomics 10:M110.002741. http://dx.doi.org/10.1074/mcp.M110.002741.
28. Harata G, He F, Hiruta N, Kawase M, Kubota A, Hiramatsu M, Yausi H. 2010. Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Lett Appl Microbiol 50:597-602. http://dx.doi.org/10.1111/j.1472-765X.2010.02844.x.
29. Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T. 1995. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child 72:51-53. http://dx.doi.org/10.1136/adc.72.1.51.
30. Lebeer S, Claes I, Tytgat HL, Verhoeven TL, Marien E, von Ossowski I, Reunanen J, Palva A, Vos WM, Keersmaecker SC, Vanderleyden J. 2012. Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl Environ Microbiol 78:185-193. http://dx.doi.org/10.1128/AEM.06192-11.
31. Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, von Wright A. 1999. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 65:351-354.
32. Lebeer S, Claes IJ, Balog CI, Schoofs G, Verhoeven TL, Nys K, von Ossowski I, de Vos WM, Tytgat HL, Agostinis P, Palva A, Van Damme EJ, Deelder AM, De Keersmaecker SC, Wuhrer M, Vanderleyden J. 2012. The major secreted protein MspI/p75 is O-glycosylated in Lactobacillus rhamnosus GG. Microb Cell Fact 11:15. http://dx.doi.org/10.1186/1475-2859-11-15.
33. Lebeer S, Verhoeven TL, Francius G, Schoofs G, Lambrichts I, Dufrene Y, Vanderleyden J, De Keersmaecker SC. 2009. Identification of a gene cluster for the biosynthesis of a long, galactose-rich exopolysaccharide in Lactobacillus rhamnosus GG and functional analysis of the priming glycosyltransferase. Appl Environ Microbiol 75:3554-3563. http://dx.doi.org/10.1128/AEM.02919-08.
34. Hugouvieux-Cotte-Pattat N, Nasser W, Robert-Baudouy J. 1994. Molecular characterization of the Erwinia chrysanthemi kdgK gene involved in pectin degradation. J Bacteriol 176:2386-2392.
35. Pouyssegur J, Stoeber F. 1974. Genetic control of the 2-keto-3-deoxy-D-gluconate metabolism in Escherichia coli K-12: kdg regulon. J Bacteriol 117:641-651.
36. Peekhaus N, Conway T. 1998. What's for dinner?: Entner-Doudoroff metabolism in Escherichia coli. J Bacteriol 180:3495-3502.
37. Francius G, Lebeer S, Alsteens D, Wildling L, Gruber HJ, Hols P, De Keersmaecker S, Vanderleyden J, Dufrene YF. 2008. Detection, localization, and conformational analysis of single polysaccharide molecules on live bacteria. ACS Nano 2:1921-1929. http://dx.doi.org/10.1021/nn800341b.
38. Landersjo C, Yang Z, Huttunen E, Widmalm G. 2002. Structural studies of the exopolysaccharide produced by Lactobacillus rhamnosus strain GG (ATCC 53103). Biomacromolecules 3:880-884. http://dx.doi.org/10.1021/bm020040q.
39. Van Geel-Schutten GH, Faber EJ, Smit E, Bonting K, Smith MR, Ten Brink B, Kamerling JP, Vliegenthart JF, Dijkhuizen L. 1999. Biochemical and structural characterization of the glucan and fructan exopolysaccharides synthesized by the Lactobacillus reuteri wild-type strain and by mutant strains. Appl Environ Microbiol 65:3008-3014.
40. Peant B, LaPointe G, Gilbert C, Atlan D, Ward P, Roy D. 2005. Comparative analysis of the exopolysaccharide biosynthesis gene clusters from four strains of Lactobacillus rhamnosus. Microbiology 151:1839-1851. http://dx.doi.org/10.1099/mic.0.27852-0.
41. Lebeer S, Claes IJ, Verhoeven TL, Vanderleyden J, De Keersmaecker SC. 2011. Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innate immune factors in the intestine. Microb Biotechnol 4:368-374. http://dx.doi.org/10.1111/j.1751-7915.2010.00199.x.
42. von Ossowski I, Reunanen J, Satokari R, Vesterlund S, Kankainen M, Huhtinen H, Tynkkynen S, Salminen S, de Vos WM, Palva A. 2010. Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits. Appl Environ Microbiol 76:2049-2057. http://dx.doi.org/10.1128/AEM.01958-09.
43. Gunaydin G, Zhang R, Hammarstrom L, Marcotte H. 2014. Engineered Lactobacillus rhamnosus GG expressing IgG-binding domains of protein G: capture of hyperimmune bovine colostrum antibodies and protection against diarrhea in a mouse pup rotavirus infection model. Vaccine 32:470-477. http://dx.doi.org/10.1016/j.vaccine.2013.11.057.
44. Maze A, Boel G, Zuniga M, Bourand A, Loux V, Yebra MJ, Monedero V, Correia K, Jacques N, Beaufils S, Poncet S, Joyet P, Milohanic E, Casaregola S, Auffray Y, Perez-Martinez G, Gibrat JF, Zagorec M, Francke C, Hartke A, Deutscher J. 2010. Complete genome sequence of the probiotic Lactobacillus casei strain BL23. J Bacteriol 192:2647-2648. http://dx.doi.org/10.1128/JB.00076-10.
45. Pant N, Marcotte H, Brussow H, Svensson L, Hammarstrom L. 2007. Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies. BMC Microbiol 7:86. http://dx.doi.org/10.1186/1471-2180-7-86.
46. Sybesma W, Molenaar D, van IJcken W, Venema K, Kort R. 2013. Genome instability in Lactobacillus rhamnosus GG. Appl Environ Microbiol 79:2233-2239. http://dx.doi.org/10.1128/AEM.03566-12.
47. Martin MC, Fernandez M, Martin-Alonso JM, Parra F, Boga JA, Alvarez MA. 2004. Nisin-controlled expression of Norwalk virus VP60 protein in Lactobacillus casei. FEMS Microbiol Lett 237:385-391. http://dx.doi.org/10.1111/j.1574-6968.2004.tb09721.x.